ARS Pharmaceuticals

IPO

ARS Pharma – Developing Biotechnology

Public · San Diego, United States · Founded 2015 · $75.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$75.0M
Last Round
$55.0M Series DAug 2021
Rounds
2
Type
Public

About

Develops and commercializes neffy, an FDA-approved needle-free epinephrine nasal spray for treating severe allergic reactions and anaphylaxis.

Summary

ARS Pharmaceuticals is a Healthcare company based in San Diego, United States, founded in 2015. It has raised $75.0M in total across 2 rounds, most recently a $55.0M Series D round in Aug 2021. Investors include RA Capital Management, Deerfield Management and SR One.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Debt FinancingLoan FacilitySep 2025
$100.0M

Sign up to see all 4 rounds

Series C through Debt Financing — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ARS Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/ars-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/ars-pharmaceuticals" alt="ARS Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>